Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Anticancer Research|August 10, 2002
Preclinical evaluation of the antitumour activity of the novel vascular targeting agent Oxi 4503Sally A Hill, Gillian M Toze, George R Pettit, et al.
Gynecologic Oncology Research and Practice|January 11, 2018
Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension managementRachel Grisham, Bonnie Ky, Krishnansu S Tewari, et al.
Vascular Pharmacology|May 20, 2015
Exaggerated hypertensive response to combretastatin A-4 phosphate in hypertensive rats: Effective pharmacological inhibition by diltiazemQingen Ke, Mohammed A Samad, Soochan Bae, et al.
Vascular Pharmacology|September 10, 2009
Pharmacological inhibition of the hypertensive response to combretastatin A-4 phosphate in ratsQingen Ke, Natalya Bodyak, Debra L Rigor, et al.
Journal of Natural Products|May 26, 2010
Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1Rajendra P Tanpure, Tracy E Strecker, David J Chaplin, et al.
Bioorganic & Medicinal Chemistry|September 3, 2013
Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3'-hydroxy-4'-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006)Matthew T Macdonough, Tracy E Strecker, Ernest Hamel, et al.
International Journal of Cancer|July 9, 2004
Combretastatin family member OXI4503 induces tumor vascular collapse through the induction of endothelial apoptosisYezhou Sheng, Jianyi Hua, Kevin G Pinney, et al.
Molecular Cancer Therapeutics|October 15, 2009
Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft modelsLaura G Daenen, Yuval Shaked, Shan Man, et al.
Anticancer Research|June 25, 2003
Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphateJianyi Hua, Yezhou Sheng, Kevin G Pinney, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2017
Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin LErica N Parker, Samuel O Odutola, Yifan Wang, et al.
Pageof 5